Perou Lab
Popular repositories Loading
-
DNA-based-predictors-of-non-genetic-cancer-phenotypes
DNA-based-predictors-of-non-genetic-cancer-phenotypes PublicR 2
-
Breast-Cancer-Modules
Breast-Cancer-Modules PublicGene expression modules used in the Perou Lab for breast cancer data exploration, machine learning analyses, etc.
-
PAM50_ER_HER2_normalization
PAM50_ER_HER2_normalization PublicPython code to apply the PAM50 gene normalization as in PMID 38546612
-
PAM50_classifier
PAM50_classifier PublicOriginal PAM50 code from Parker et al., JCO 2009, PMID: 19204204
-
iGES_scores
iGES_scores PublicPrognostic value of immune gene-expression signatures versus tumor-infiltrating lymphocytes in early-stage HER2-positive breast cancer: a correlative analysis of CALGB 40601 and PAMELA trials
R 1
Repositories
- CALGB40603_PrePost_Analyses Public
CALGB 40603 was a phase II clinical trial that evaluated the effects of adding carboplatin or bevacizumab to a NACT regimen of weekly paclitaxel, followed by dose-dense doxorubicin and cyclophosphamide, in patients with stage II/III TNBC. Here we provide code for Rädler et al., JCI, 2026 (PMID:42550611, DOI: 10.1172/JCI205962)
- Breast-Cancer-Modules Public
Gene expression modules used in the Perou Lab for breast cancer data exploration, machine learning analyses, etc.
- mouse-mammary-tumor-modeling Public
- CALGB-40603-TNBC-survival-models Public
Code and data used to train and evaluate the TNBC survival models in "Prognostic and molecular multi-platform analysis of CALGB 40603 (Alliance) and public triple-negative breast cancer datasets" (Felsheim et al. NPJ Breast Cancer 2025, PMID: 40057511)
- GOF Public Forked from siyao-liu/GOF
Feature selection for clustering scRNA-seq data using goodness of fit measures
- CraftedExperiment Public Forked from siyao-liu/CraftedExperiment
Generate crafted datasets based on real scRNA-seq data
- PAM50_ER_HER2_normalization Public
Python code to apply the PAM50 gene normalization as in PMID 38546612
- iGES_scores Public
Prognostic value of immune gene-expression signatures versus tumor-infiltrating lymphocytes in early-stage HER2-positive breast cancer: a correlative analysis of CALGB 40601 and PAMELA trials
People
This organization has no public members. You must be a member to see who’s a part of this organization.
Top languages
Loading…
Most used topics
Loading…